Safe administration of muscle-relaxing botulismotoxin during treatment for leukemia.
Lo Nigro
Luca
L
Costantino
Francesco
F
Schilirò
Gino
G
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D009128:Muscle Spasticity / Q000150:complications / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications*
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins